Serum antibodies to heparan sulfate glycosaminoglycans in Guillain–Barré syndrome and other demyelinating polyneuropathies
- 1 November 1998
- journal article
- Published by Elsevier BV in Journal of Neuroimmunology
- Vol. 91 (1-2), 204-209
- https://doi.org/10.1016/s0165-5728(98)00182-9
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Changing views of guillain‐barré syndromeAnnals of Neurology, 1997
- Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathyAnnals of Neurology, 1996
- Immunopathogenesis and treatment of the guillain‐barré syndrome—part IMuscle & Nerve, 1995
- Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndromeAnnals of Neurology, 1992
- Identification of a lipid-anchored heparan sulfate proteoglycan in Schwann cells.The Journal of cell biology, 1990
- Assessment of current diagnostic criteria for Guillain-Barr syndromeAnnals of Neurology, 1990
- Serum antibodies to gangliosides in guillain‐barré syndromeAnnals of Neurology, 1988
- AN ACUTE AXONAL FORM OF GUILLAIN-BARRÉE POLYNEUROPATHYBrain, 1986
- Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes.JCI Insight, 1986
- An Unusual Variant of Acute Idiopathic Polyneuritis (Syndrome of Ophthalmoplegia, Ataxia and Areflexia)New England Journal of Medicine, 1956